Antibiotics: Leveraging Off-Label Efficacy Data Needed To Drive Appropriate Use, Reimbursement

 
• By Sue Sutter
  
PS1911_Antimicrobial_392702734_1200.jpg
Infectious disease specialists want more data in antibacterial product labeling about efficacy against resistant pathogens. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Marketing & Advertising

More from Compliance